The Effect of Welchol on Glucose Metabolism in Type 2 Diabetics
Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
The goal of this study was to determine the metabolic mechanism for a certain type
medication's ability to lower blood sugar after a meal in Type 2 Diabetics, in order to
develop a better understanding of it's potential role in the treatment of obesity.
Phase:
Phase 4
Details
Lead Sponsor:
Mayo Clinic
Collaborators:
Daiichi Sankyo Inc. Daiichi Sankyo, Inc. National Center for Research Resources (NCRR) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)